Genetics in Medicine OpenGenetic & Genomic MedicinePeer-reviewed journal article
Detection of mosaic chromosomal alterations in children with severe developmental disorders recruited to the DDD study
Ruth Y. EberhardtiD, Caroline Fiona WrightiD, David R FitzPatrickiD, Matthew E. HurlesiD, Helen V. FirthiD
Abstract
PurposeStructural mosaicism has been previously implicated in developmental disorders. We aim to identify rare mosaic chromosomal alterations (MCAs) in probands with severe undiagnosed developmental disorders. MethodsWe identified MCAs in SNP array data from 12,530 probands in the Deciphering Developmental Disorders (DDD) study using MoChA. ResultsWe found 61 MCAs in 57 probands, many of these were tissue specific. In 23/26 (88.5%) cases for which the MCA was detected in saliva where blood was also available for analysis, the MCA could not be detected in blood. The MCAs included 20 polysomies, comprising either one arm of a chromosome or a whole chromosome, for which we were able to show the timing of the error (25% mitosis, 40% meiosis I, 35% meiosis II). Only 2/57 (3.5%) of the probands in whom we found MCAs had another likely genetic diagnosis identified by whole exome sequencing, despite an overall diagnostic yield of [~]40% across the cohort. ConclusionOur results show that identification of MCAs provides candidate diagnoses for previously undiagnosed patients with developmental disorders, potentially explaining [~]0.45% of cases in the DDD study. Nearly 90% of these MCAs would have remained undetected by analysing DNA from blood and no other tissue.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 5
- FWCI
- 0.66
- Field percentile
- top 33%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Detection of structural mosaicism from targeted and whole-genome sequencing data
Daniel A King, Alejandro Sifrim, … The Deciphering Developmental Disorders Study·Genome ResearchPeer-reviewed·Aug 30, 2017
- Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions
Charles H. Hensel, Rena J. Vanzo, … Edward Robert Wassman·PLoS CurrentsPeer-reviewed·Jan 1, 2017
- Detecting cryptic clinically-relevant structural variation in exome sequencing data increases diagnostic yield for developmental disorders
Eugene J. Gardner, Alejandro Sifrim, … Matthew E. Hurles·The American Journal of Human GeneticsPeer-reviewed·Oct 8, 2021
- Early post-zygotic mutations contribute to congenital heart disease
Alexander Hsieh, Sarah U. Morton, … Yufeng Shen·bioRxiv·Aug 13, 2019
- Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature
Christy W. LaFlamme, Cassandra Rastin, … Heather C. Mefford·Nature CommunicationsPeer-reviewed·Aug 6, 2024
- Optimising diagnostic yield in highly penetrant genomic disease
Caroline Fiona Wright, Patrick H. Campbell, … Helen V. Firth·medRxiv·Jul 25, 2022